Imaging Stroke Patients with Unclear Onset Times

Neuroimaging Clinics of North America

Volumn 21, Issue 2, 2011, Pages 327-344

  Wu, Ona ^a   Schwamm, Lee H ^b   Sorensen, A Gregory ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain ischemia; Diffusion magnetic resonance imaging; Perfusion magnetic resonance imaging; Stroke; Thrombolytic therapy; Time

Indexed keywords

ABCIXIMAB; ALTEPLASE; DESMOTEPLASE; PLACEBO;

AROUSAL; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); COMBINATION CHEMOTHERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG WITHDRAWAL; EMERGENCY HEALTH SERVICE; FLUID ATTENUATED INVERSION RECOVERY; HUMAN; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY; MISMATCH NEGATIVITY; MONOTHERAPY; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OUTCOME ASSESSMENT; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RECANALIZATION; REVIEW; SALVAGE THERAPY; SENSITIVITY AND SPECIFICITY; STROKE; STROKE PATIENT; WAKEFULNESS;

CEREBRAL ANGIOGRAPHY; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; PERFUSION IMAGING; STROKE;

EID: 79957803760     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2011.02.008     Document Type: Review

References (93)

1. Miniño A.M., Xu J.Q., Kochanek K.D. Deaths: preliminary data for 2008. National Vital Statistics Reports 2010, vol. 59. National Center for Health Statistics, Hyattsville (MD).
2. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119(3):e21-e181.
3. Rymer M.M., Thrutchley D.E. Organizing regional networks to increase acute stroke intervention. Neurol Res 2005, 27(Suppl 1):S9-S16.
4. George M.G., Tong X., McGruder H., et al. Paul Coverdell National Acute Stroke Registry Surveillance-four states, 2005-2007. MMWR Surveill Summ 2009, 58(7):1-23.
5. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359(13):1317-1329.
6. Barreto A.D., Martin-Schild S., Hallevi H., et al. Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009, 40(3):827-832.
7. Lago A., Geffner D., Tembl J., et al. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke 1998, 29(9):1873-1875.
8. Chaturvedi S., Adams H.P., Woolson R.F. Circadian variation in ischemic stroke subtypes. Stroke 1999, 30(9):1792-1795.
9. Serena J., Davalos A., Segura T., et al. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 2003, 16(2):128-133.
10. Marler J.R., Price T.R., Clark G.L., et al. Morning increase in onset of ischemic stroke. Stroke 1989, 20(4):473-476.
11. Marshall J. Diurnal variation in occurrence of strokes. Stroke 1977, 8(2):230-231.
12. Argentino C., Toni D., Rasura M., et al. Circadian variation in the frequency of ischemic stroke. Stroke 1990, 21(3):387-389.
13. Adams H.J., Bedndixen B., Kappelle J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
14. Elliott W.J. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998, 29(5):992-996.
15. Fink J.N., Kumar S., Horkan C., et al. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002, 33(4):988-993.
16. Todo K., Moriwaki H., Saito K., et al. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006, 21(5-6):367-371.
17. Silva G.S., Lima F.O., Camargo E.C., et al. Wake-up stroke: clinical and neuroimaging characteristics. Cerebrovasc Dis 2010, 29(4):336-342.
18. Iosif C., Oppenheim C., Trystram D., et al. MR imaging-based decision in thrombolytic therapy for stroke on awakening: report of 2 cases. AJNR Am J Neuroradiol 2008, 29(7):1314-1316.
19. Hellier K.D., Hampton J.L., Guadagno J.V., et al. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 2006, 77(3):417-419.
20. Adams H.P., Leira E.C., Torner J.C., et al. Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial. Stroke 2008, 39(12):3277-3282.
21. Adams H.P., Effron M.B., Torner J., et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT-II). Stroke 2008, 39(1):87-99.
22. Cho A.H., Sohn S.I., Han M.K., et al. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008, 25(6):572-579.
23. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333(24):1581-1587.
24. del Zoppo G.J., Saver J.L., Jauch E.C., et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40(8):2945-2948.
25. Moseley M.E., Cohen Y., Mintorovitch J., et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion and T2 weighted MRI and spectroscopy. Magn Reson Med 1990, 14(2):330-346.
26. Mintorovitch J., Moseley M.E., Chileuitt L., et al. Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med 1991, 18(1):39-50.
27. Jiang Q., Zhang Z.G., Chopp M., et al. Temporal evolution and spatial distribution of the diffusion constant of water in rat brain after transient middle cerebral artery occlusion. J Neurol Sci 1993, 120(2):123-130.
28. Knight R.A., Dereski M.O., Helpern J.A., et al. Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats. Stroke 1994, 25(6):1252-1261. [discussion: 1261-2].
29. Thomalla G., Rossbach P., Rosenkranz M., et al. Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less. Ann Neurol 2009, 65(6):724-732.
30. Ebinger M., Galinovic I., Rozanski M., et al. Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock?. Stroke 2010, 41(2):250-255.
31. Aoki J., Kimura K., Iguchi Y., et al. FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci 2010, 293(1-2):39-44.
32. Petkova M., Rodrigo S., Lamy C., et al. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology 2010, 257(3):782-792.
33. Barber P.A., Hill M.D., Eliasziw M., et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005, 76(11):1528-1533.
34. Universitätsklinikum Hamburg-Eppendorf. Identification of stroke patients _3 and _4.5 hours of symptom onset by fluid attenuated inversion recovery (FLAIR) imaging and diffusion weighted imaging (DWI) (PRE-FLAIR). In: Bethesda (MD): National Library of Medicine (US); 2000. Available from: ; 2000. NLM Identifier: NCT01021319, Accessed January 4, 2011. http://clinicaltrials.gov/ct2/show/NCT01021319.
35. Siemonsen S., Mouridsen K., Holst B., et al. Quantitative t2 values predict time from symptom onset in acute stroke patients. Stroke 2009, 40(5):1612-1616.
36. Jones S.C., Kharlamov A., Yanovski B., et al. Stroke onset time using sodium MRI in rat focal cerebral ischemia. Stroke 2006, 37(3):883-888.
37. Thulborn K.R., Gindin T.S., Davis D., et al. Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. Radiology 1999, 213(1):156-166.
38. Hussain M.S., Stobbe R.W., Bhagat Y.A., et al. Sodium imaging intensity increases with time after human ischemic stroke. Ann Neurol 2009, 66(1):55-62.
39. Tsang A., Stobbe R.W., Asdaghi N., et al. Relationship between sodium intensity and perfusion deficits in acute ischemic stroke. J Magn Reson Imaging 2011, 33(1):41-47.
40. Jokivarsi K.T., Hiltunen Y., Grohn H., et al. Estimation of the onset time of cerebral ischemia using T1rho and T2 MRI in rats. Stroke 2010, 41(10):2335-2340.
41. Grohn O.H., Lukkarinen J.A., Silvennoinen M.J., et al. Quantitative magnetic resonance imaging assessment of cerebral ischemia in rat using on-resonance T(1) in the rotating frame. Magn Reson Med 1999, 42(2):268-276.
42. Grohn O.H.J., Kettunen M.I., Makela H.I., et al. Early detection of irreversible cerebral ischemia in the rat using dispersion of the magnetic resonance imaging relaxation time, T1rho. J Cereb Blood Flow Metab 2000, 20(10):1457-1466.
43. Geisler B.S., Brandhoff F., Fiehler J., et al. Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006, 37(7):1778-1784.
44. Kohrmann M., Juttler E., Fiebach J.B., et al. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006, 5(8):661-667.
45. Schellinger P.D., Thomalla G., Fiehler J., et al. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007, 38(10):2640-2645.
46. Welch K.M.A., Windham J., Knight R.A., et al. A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke 1995, 26(11):1983-1989.
47. Helpern J.A., Dereski M.O., Knight R.A., et al. Histopathological correlations of nuclear magnetic resonance imaging parameters in experimental cerebral ischemia. Magn Reson Imaging 1993, 11(2):241-246.
48. Jiang Q., Chopp M., Zhang Z.G., et al. The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat. J Neurol Sci 1997, 145(1):15-23.
49. Hajnal J.V., Bryant D.J., Kasuboski L., et al. Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain. J Comput Assist Tomogr 1992, 16(6):841-844.
50. Schwamm L.H., Koroshetz W.J., Sorensen A.G., et al. Time course of lesion development in patients with acute stroke: serial diffusion- and hemodynamic-weighted magnetic resonance imaging. Stroke 1998, 29:2268-2276.
51. Gaudinski M.R., Henning E.C., Miracle A., et al. Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant. Stroke 2008, 39(10):2765-2768.
52. Fisher M., Feuerstein G., Howells D.W., et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40(6):2244-2250.
53. Copen W.A., Schwamm L.H., Gonzalez R.G., et al. Ischemic stroke: effects of etiology and patient age on the time course of the core apparent diffusion coefficient. Radiology 2001, 221(1):27-34.
54. Ebinger M., Ostwaldt A.C., Galinovic I., et al. Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysis. Stroke 2010, 41(8):1823-1825.
55. Tong D.C., Adami A., Moseley M.E., et al. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000, 31(10):2378-2384.
56. Oppenheim C., Samson Y., Dormont D., et al. DWI prediction of symptomatic hemorrhagic transformation in acute MCA infarct. J Neuroradiol 2002, 29(1):6-13.
57. Fiehler J., Foth M., Kucinski T., et al. Severe ADC decreases do not predict irreversible tissue damage in humans. Stroke 2002, 33(1):79-86.
58. Loh P.S., Butcher K.S., Parsons M.W., et al. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis. Stroke 2005, 36(12):2626-2631.
59. Nagesh V., Welch K.M.A., Windham J.P., et al. Time course of ADCw changes in ischemic stroke: beyond the human eye!. Stroke 1998, 29:1778-1782.
60. Miyabe M., Mori S., van Zijl P.C., et al. Correlation of the average water diffusion constant with cerebral blood flow and ischemic damage after transient middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1996, 16(5):881-891.
61. Jones T.H., Morawetz R.B., Crowell R.M., et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981, 54(6):773-782.
62. Fiehler J., Knudsen K., Kucinski T., et al. Predictors of apparent diffusion coefficient normalization in stroke patients. Stroke 2004, 35(2):514-519.
63. Kidwell C.S., Alger J.R., Saver J.L. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 2003, 34(11):2729-2735.
64. Li F., Han S.S., Tatlisumak T., et al. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats. Ann Neurol 1999, 46(3):333-342.
65. Marks M.P., Tong D.C., Beaulieu C., et al. Evaluation of early reperfusion and i.v. tPA therapy using diffusion- and perfusion-weighted MRI. Neurology 1999, 52(9):1792-1798.
66. Kidwell C.S., Saver J.L., Mattiello J., et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann Neurol 2000, 47(4):462-469.
67. Dijkhuizen R.M., Knollema S., van der Worp H.B., et al. Dynamics of cerebral tissue injury and perfusion after temporary hypoxia-ischemia in the rat: evidence for region-specific sensitivity and delayed damage. Stroke 1998, 29(3):695-704.
68. van Lookeren Campagne M., Thomas G.R., Thibodeaux H., et al. Secondary reduction in the apparent diffusion coefficient of water, increase in cerebral blood volume, and delayed neuronal death after middle cerebral artery occlusion and early reperfusion in the rat. J Cereb Blood Flow Metab 1999, 19(12):1354-1364.
69. Li F., Silva M.D., Liu K.F., et al. Secondary decline in apparent diffusion coefficient and neurological outcomes after a short period of focal brain ischemia in rats. Ann Neurol 2000, 48(2):236-244.
70. Li F., Liu K.F., Silva M.D., et al. Acute postischemic renormalization of the apparent diffusion coefficient of water is not associated with reversal of astrocytic swelling and neuronal shrinkage in rats. AJNR Am J Neuroradiol 2002, 23(2):180-188.
71. Li F., Han S., Tatlisumak T., et al. A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion- and perfusion-weighted imaging. Stroke 1998, 29(8):1715-1719. [discussion: 1719-20].
72. Rosen B., Belliveau J., Vevea J., et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990, 14(2):249-266.
73. Williams D.S., Detre J.A., Leigh J.S., et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A 1992, 89(1):212-216.
74. Sorensen A.G., Buonanno F.S., Gonzalez R.G., et al. Hyperacute stroke: evaluation with combined multisection diffusion-weighted and hemodynamically weighted echo-planar MR imaging. Radiology 1996, 199:391-401.
75. Sorensen A.G., Copen W.A., Østergaard L., et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. Radiology 1999, 210(2):519-527.
76. Warach S., Dashe J.F., Edelman R.R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 1996, 16(1):53-59.
77. Baird A.E., Warach S. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 1998, 18(6):583-609.
78. Shih L.C., Saver J.L., Alger J.R., et al. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke 2003, 34(6):1425-1430.
79. Albers G.W., Thijs V.N., Wechsler L., et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 2006, 60(5):508-517.
80. Davis S.M., Donnan G.A., Parsons M.W., et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008, 7(4):299-309.
81. Hacke W., Albers G., Al-Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36(1):66-73.
82. Furlan A.J., Eyding D., Albers G.W., et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37(5):1227-1231.
83. Hacke W., Furlan A.J., Al-Rawi Y., et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 2009, 8(2):141-150.
84. Singhal A.B., Benner T., Roccatagliata L., et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke 2005, 36(4):797-802.
85. CoAxia. Safety and efficacy of NeuroFlo in 8-24 hour stroke patients (Flo 24). ClinicalTrials.gov 2000, National Library of Medicine (US), Bethesda (MD), Available from:, NLM Identifier: NCT00436592, Accessed January 9, 2011. http://clinicaltrials.gov/ct2/show/NCT00436592.
86. National Stroke Research Institute Australia Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND). ClinicalTrials.gov 2000, National Library of Medicine (US), Bethesda (MD), Available from:, NLM Identifier: NCT00887328, Accessed January 9, 2011. http://clinicaltrials.gov/ct2/show/NCT00887328.
87. University of California Los Angeles Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE). ClinicalTrials.gov 2000, National Library of Medicine (US), Bethesda (MD), Available from:, NLM Identifier: NCT00389467, Accessed January 9, 2011. http://clinicaltrials.gov/ct2/show/NCT00389467.
88. National Institute of Neurological Disorders and Stroke. NINDS Awards Recovery Act Funds to Support Neuroimaging Study of Stroke Patients Available from:, Accessed January 9, 2011. http://www.ninds.nih.gov/recovery/arra-stories/Albers-Defuse.htm.
89. Lundbeck A/S H. Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke (DIAS-4). ClinicalTrials.gov 2000, National Library of Medicine (US), Bethesda (MD), Available from:, NLM Identifier:NCT00856661, Accessed January 9, 2011. http://clinicaltrials.gov/ct2/show/NCT00856661.
90. University of California San Diego Study for the Use of Alteplase in Patients Who Awaken With Stroke (AWOKE). ClinicalTrials.gov 2000, National Library of Medicine (US), Bethesda (MD), Available from:, Identifier:NCT01150266, Accessed January 9, 2011. http://clinicaltrials.gov/ct2/show/NCT01150266.
91. University of Texas Health Science Center Houston Safety of Intravenous Thrombolysis for Wake-up Stroke (Wake-Up Stroke). ClinicalTrials.gov 2000, National Library of Medicine (US), Bethesda (MD), Available from:, Identifier:NCT01183533, Accessed January 9, 2011. http://clinicaltrials.gov/ct2/show/NCT01183533.
92. Schwamm LH, Sorensen AG, Wu O, et al. MR WITNESS Investigators. MR WITNESS-Safety Trial of IV rt-PA in Patients With Unwitnessed Stroke Onset. 2010 International Stroke Conference. San Antonio (TX), February 24-26, 2010.
93. Wu O, Song SS, Ritter C, et al. MRI as witness: ready for prime-time? 2011 International Stroke Conference. Los Angeles (CA), Feburary 9-11, 2011.